Because nucleolin is a membrane protein that serves as a binding receptor for various ligands involved in cancer pathogenesis, it represents a potential strategic target for cancer therapy and an attractive target for several types of malignancies, including AML [79,80]. The gene discussed is NUCLEOLIN; the disease is acute myeloid leukemia.